Ito H, Kyo S, Kanaya T, Takakura M, Inoue M, Namiki M
Department of Urology, School of Medicine, Kanazawa University, Ishikawa, Japan.
Clin Cancer Res. 1998 Jul;4(7):1603-8.
The activation of telomerase and stabilization of telomeres are thought to be required for cellular immortality and oncogenesis. Three major components of human telomerase--human telomerase RNA (hTERC), telomerase-associated protein (TEP1), and human telomerase catalytic subunit (hTERT)-have recently been identified. However, the roles played by these subunits in the regulation of telomerase activity are still unclear. In the present study, a total of 37 urothelial cancers, including one metastatic lesion, and adjacent normal tissues as well as cell lines derived from bladder cancers were examined for the expression of each telomerase subunit. Reverse transcription-PCR analysis revealed that more than 90% of urothelial cancers expressed hTERT mRNA, whereas less than 20% of normal adjacent tissues did. In contrast, hTERC and TEP1 mRNA were commonly expressed in both cancers and normal tissues. All of the three cell lines derived from bladder cancer expressed each of the telomerase subunits, whereas the two normal primary fibroblast cell lines expressed hTERC and TEP1 mRNA but not hTERT mRNA. Telomerase activity was examined using telomeric repeat amplification protocol assay. All of the cancers examined exhibited telomerase activity, whereas only 2 of 12 normal tissues exhibited weak activity. There was a significant association of telomerase activity with hTERT mRNA expression but not with hTERC or TEP1 mRNA expression. These findings provide strong evidence that the expression of hTERT is a rate-limiting determinant of the enzymatic activity of human telomerase and that the up-regulation of hTERT expression may play a critical role in human carcinogenesis.
端粒酶的激活和端粒的稳定被认为是细胞永生化和肿瘤发生所必需的。人类端粒酶的三个主要成分——人类端粒酶RNA(hTERC)、端粒酶相关蛋白(TEP1)和人类端粒酶催化亚基(hTERT)——最近已被鉴定出来。然而,这些亚基在端粒酶活性调节中所起的作用仍不清楚。在本研究中,对总共37例尿路上皮癌(包括1例转移灶)、相邻正常组织以及源自膀胱癌的细胞系进行了各端粒酶亚基表达的检测。逆转录 - PCR分析显示,超过90%的尿路上皮癌表达hTERT mRNA,而相邻正常组织中表达该mRNA的比例不到20%。相比之下,hTERC和TEP1 mRNA在癌症组织和正常组织中均普遍表达。源自膀胱癌的所有三个细胞系均表达各端粒酶亚基,而两个正常原代成纤维细胞系表达hTERC和TEP1 mRNA,但不表达hTERT mRNA。使用端粒重复序列扩增协议分析法检测端粒酶活性。所有检测的癌症均表现出端粒酶活性,而12例正常组织中只有2例表现出微弱活性。端粒酶活性与hTERT mRNA表达存在显著相关性,但与hTERC或TEP1 mRNA表达无关。这些发现提供了强有力的证据,表明hTERT的表达是人类端粒酶酶活性的限速决定因素,并且hTERT表达的上调可能在人类致癌过程中起关键作用。